ロード中...
Meaningful patient representation informing Canada’s cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug Review
In this interview with the patient representatives on the Expert Review Committee (perc) of the Pan-Canadian Oncology Drug Review (pcodr), those representatives offer their views about how to be a valuable contributing member of Canada’s national cancer drug funding recommendation committee. The art...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Multimed Inc.
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4189566/ https://ncbi.nlm.nih.gov/pubmed/25302034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.21.2128 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|